[1] |
于鹏,王瑞民,徐白萱, 等. 超声乳腺影像报告和数据系统与18F-FDG PET/CT在乳腺疾病诊断中的相关性及联合应用价值 [J]. 中国医学影像学杂志, 2014, (10):730-734.
|
[2] |
朱朝晖. PET /CT在肿瘤学中的应用. 现代仪器 [J]. 2006, (4):16-18.
|
[3] |
Liberman L, Menell JH. Breast imaging reporting and data system (BI-RADS) [J]. Radiol Clin North Am, 2002, 40(3):409-430.
|
[4] |
Greco M, Crippa F, Agresti R, et a1. Axillary lymph node staging in breast cancer by 2-fluoro-2-deoxy-D-glucose-positron emission tomography: clinical evaluation and alternative management [J]. J Natl Cancer Inst, 2001, 93(8):630-635.
|
[5] |
Kelly KM, Dean J, Comulada WS, et al. Breast cancer detection using automated whole breast ultrasound and mammography in radiographically dense breasts [J]. Eur Radiol, 2010, 20(3):734-742.
|
[6] |
Watermann DO, Foldi M, Hanjalic-Beck A, et al. Three-dimensional ultrasound for the assessment of breast lesions [J]. Ultrasound Obstet Gynecol, 2005, 25(6):592-598.
|
[7] |
Lin X, Wang J, Han F, et al. Analysis of eighty-one cases with breast lesions using automated breast volume scanner and comparison with handheld ultrasound [J]. Eur J Radiol, 2011, doi: 10.1016/j.ejrad.2011.02.038
|
[8] |
Wöhrle NK, Hellerhof K, Notohamiprodjo M, et al. Automated breast volume scanner (ABVS). A new approach for breast imaging [J]. Der Onkologe, 2011, doi: 10.1007/s00761-011-2040-x [in German].
|
[9] |
Richter K, Heywang-Kobrunner SH, Winzer KJ, et al. Detection of malignant and benign breast lesions with an automated US system: results in 120 cases [J]. Radiology, 1997, 205:823-830.
|
[10] |
Chou YH, Tiu CM, Chen J, et al. Automated full-field breast ultrasonography: the past and the present [J]. J Med Ultrasound, 2007, 15(1):31-44.
|
[11] |
Avril N, Dose J, Jänicke F, et al. Metabolic characterization of breast tumors with positron emission tomography using F-18 fluorodeoxyglucose [J]. J Clin Oncol, 1996, 14(6):1848-1857.
|
[12] |
Crowe JP Jr, Adler LP, Shenk RR, et al. Positron emission tomography and breast masses: com parison with clinical mammographic, and pathological findings [J]. Ann Surg Oncol, 1994, 1(2):132-140.
|
[13] |
Scheidhauer K, Scharl A, Pietrzyk U, et al. Qualitative 18F-FDG positron emission tomography in primary breast cancer: clinical relevance and practicability [J]. Eur J Nucl Med, 1996, 23(6):618-623.
|
[14] |
Tse NY, Hoh CK, Hawkins RA, et al. The application of positron emission tomograpic imaging with fluorodeoxyglucose to the evaluat on of breast disease [J]. Ann Surg, 1992, 216(1):27-34.
|
[15] |
Buck A, Schirrmeister H, Khn T, et al. FDG uptake in breast cancer: correlation with biologica l and clinical prognostic parameters [J]. Eur J Nucl Med Mol Imaging, 2002, 29(10):1317-1323.
|
[16] |
Heusner TA, Kuemmel S, Hahn S, et al. Diagnostic value of full-dose FDG PET/CT for axillary lymph node staging in breast cancer patients [J]. Eur J Nucl Med Mol Imaging, 2009, 36(10):1543-1550.
|
[17] |
Inokuchi M, Furukawa H, Kayahara M,et al. The role of 18FDG PET-CT for the initial staging and therapy in primary breast cancer [J]. Gan To Kagaku Ryoho, 2009, 36(13):2526-2531.
|
[18] |
Peare R, Staff RT, Heys SD. The use of FDG-PET in assessing axillary lymph node status in breast cancer: A systematic review and meta-analysis of the literature [J]. Breast Cancer Res Treat, 2010, 123(1):281-290.
|
[19] |
Kim J, Lee J, Chang E, et al. Selective sentinel node plus additional non-sentinel node biopsy based on an FDG-PET/CT scan in early breast cancer patients: Single institutional experience [J]. World J Surg, 2009, 33(5):943.
|
[20] |
Choi YJ, Shin YD, Kang YH, et al. The Effects of Preoperative 18F-FDG PET/CT in Breast Cancer Patients in Comparison to the Conventional Imaging Study [J]. J Breast Cancer, 2012, 15(4):441-448.
|
[21] |
Mahner S, Schirrmacher S, Brenner W, et al. Comparison between positron emission tomography using 2-[fluorine-18] fluoro-2-deoxy-D-glucose, conventional imaging and computed tomography for staging of breast cancer [J]. Ann Oncol, 2008, 19(7):1249-1254.
|